Introduction An audit on the management of neonatal hyperglycaemia in a tertiary neonatal unit in 2012 revealed that 42% of infants needed more than 72 h of insulin therapy to achieve euglycaemia and similar percentage had high insulin requirements (>0.1 u/kg/hr). Variable insulin release secondary to adsorption in the infusion tubing or insulin resistance was considered the likely mechanism. Iatrogenic hypoglycaemia was seen in a third of infants within hours of stopping insulin infusion, possibly related to residual insulin in the central line. Hence the following changes in practice were recommended- a) pre-infusion priming of intravenous tubings for stable insulin delivery b) earlier upgrading of insulin sliding-scale to help with insulin resistance and c) insulin administration preferably via peripheral route to decrease the risk of iatrogenic hypoglycaemia.
Aims A re-audit was carried out after one year to assess the impact of above changes.
Methods Prospective case notes review of all admitted infants needing insulin for hyperglycaemia between January-June 2013.
Results Twenty-six hyperglycaemic episodes in 19 of the 175 admitted infants were audited. There was 100% compliance with line priming and all but one infant had insulin via peripheral cannula. All were born <28 weeks gestation and all but one were <1 kg at birth. Fifty percent of these episodes occurred within 72 h of birth. In 10 of the 26 episodes (40%), euglycaemia was achieved within 24 h compared to only 16% in the initial audit. Only 7 of the 26 (27%) episodes needed more than 72 h of insulin treatment to achieve euglycaemia compared to 42% in the previous audit. Iatrogenic hypoglycaemia was seen in only 1 episode (4%) as compared to 33% in the initial audit. Eleven of the 26 (42%) infants needed >0.1 u/kg/hour of insulin infusion by upgrading the sliding-scale with no iatrogenic hypoglycaemia in this group.
Conclusions The implementation of line priming with insulin along with early upgrading of sliding-scale led to early achievement of euglycaemia without any adverse effects. We also recommend insulin administration preferably via peripheral cannula to reduce the risk of iatrogenic hypoglycaemia.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.